Regulatory Roadblock for Zydus: CDSCO Panel Halts MMRV Vaccine Trial, Seeks Adult Data Dr. Divya Colin18 Aug 2025 4:15 PM ISTNew Delhi: Zydus Lifesciences Limited's plan to conduct a Phase II/III clinical trial of its Measles, Mumps, Rubella and Varicella (MMRV) vaccine has...
Zydus Lifesciences Reports Rs 6,573.7 Cr Revenue in Q1 FY26, Net Profit Rises 3% Parthika Patel14 Aug 2025 2:00 PM ISTNew Delhi: Zydus Lifesciences Limited has announced its unaudited consolidated financial results for the first quarter ended June 30, 2025, reporting...
USFDA concludes inspection at Zydus Lifesciences SEZ II, Ahmedabad plant Ruchika Sharma14 Aug 2025 1:30 PM ISTAhmedabad: Zydus Lifesciences has announced that the US Food and Drug Administration (USFDA) has concluded inspection at the group’s...
Zydus Lifesciences gets 4 USFDA observations for Baddi plant Ruchika Sharma14 Aug 2025 11:22 AM ISTAhmedabad: Zydus Lifesciences has announced that the company has received 4 observations from the US Food and Drug Administration (USFDA) after...
USFDA approves Zydus Lifesciences chronic idiopathic constipation drug Prucalopride Ruchika Sharma11 Aug 2025 2:30 PM ISTAhmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for...
Zydus bags USFDA nod for chronic stable angina drug Diltiazem Hydrochloride Ruchika Sharma11 Aug 2025 11:30 AM ISTAhmedabad: Zydus Lifesciences Limited has announced that the company has received final approval from the United States Food and Drug...
Zydus Lifesciences gets NOC from Health Canada for ZDS-Varenicline tablets Ruchika Sharma8 Aug 2025 10:00 AM ISTAhmedabad: Zydus Lifesciences Limited has received NOC (Notice of Compliance) from Health Canada for ZDS-Varenicline tablets 0.5 &1 mg. This...
Zydus Told To Conduct Phase III Trial in India for Lurbinectedin Injection, BE Study Waived Parthika Patel31 July 2025 1:49 PM ISTNew Delhi: Zydus Lifesciences Limited has been directed to conduct a Phase III clinical trial in the Indian population for its proposed oncology drug...
Zydus completes acquisition of 85.6% stake in Amplitude Surgical Ruchika Sharma30 July 2025 2:30 PM ISTAhmedabad: Zydus Lifesciences Limited has announced the completion of the acquisition of an 85.6 percent stake in Amplitude Surgical.The deal...
Zydus Lifesciences receives tentative approval from USFDA for Chronic lymphocytic leukaemia drug Ibrutinib Ruchika Sharma24 July 2025 3:24 PM ISTAhmedabad: Zydus Lifesciences Limited has announced that it has received tentative approval from the United States Food and Drug Administration...
Delhi HC Bars Zydus From Launching Cancer Drug Nivolumab Biosimilar Till 2026 Farhat Nasim23 July 2025 4:45 PM ISTNew Delhi: In a major setback to Zydus Lifesciences, the Delhi High Court has restrained the company from launching its proposed biosimilar of the...
Zydus Matoda facility completes USFDA Remote Regulatory Assessment Ruchika Sharma17 July 2025 11:24 AM ISTAhmedabad: Zydus Lifesciences has announced that the U.S. Food and Drug Administration (USFDA) has conducted a Remote Regulatory Assessment (RRA)...
